Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q2 2022 · 10-Q
Revenue$7.97K$7.97Kno prior Q2 2021 on file Net Income-$491.56K-$491.56Kno prior Q2 2021 on file EPS, diluted—
Operating Income-$491,500— The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
Operating Cash Flowderived-$17,628— Free Cash Flowderived-$8,017— Margins · derivedGross margin73.4%
Operating margin-6166.9%
Net margin-6167.6%
ended Jun 30, 2022 · filed Aug 15, 2022 · 46 d after period end